Another report, from rhabdomyosarcoma, has identified amplified, overexpressed, and constitutively activated PDGFRα as an acquired resistance mechanism to an agent targeting insulin-like growth factor I receptor (IGF-IR) [103]. Here, IGF1R is linked to rhabdomyosarcoma.